Inpatient Evaluation of Syncope: Risk Stratification Updates From May 2017

Syncope is a brief loss of consciousness caused by transient global cerebral hypoperfusion, followed by spontaneous recovery. Although many episodes are benign reflex faints, the same presentation can signal arrhythmia, structural heart disease, pulmonary embolism, haemorrhage or a dangerous neurological mimic. The central hospital medicine task is to identify patients whose short-term risk is high enough to justify monitored care.

The May 2017 discussion reflected a shift away from treating every faint as an automatic admission. Risk stratification was becoming more deliberate: clinicians were encouraged to combine the history, physical examination, electrocardiogram, comorbidities and circumstances of the event rather than rely on a single score. This approach remains particularly relevant in Australia, where a patient may move between a metropolitan emergency department, a short-stay unit and a rural referral hospital.

The educational material associated with the Hospital Medicine 2017 programme placed syncope within broader conversations about safer inpatient decisions, clinical data and practical hospital systems. For Australian hospitalists, the useful lesson is less about memorising a 2017 algorithm and more about recognising which findings demand monitoring, specialist review or urgent treatment.

Why Syncope Needs Hospital-Level Judgment

A faint during prolonged standing in a warm room, with a typical prodrome and rapid recovery, is usually lower risk than sudden collapse during exertion. However, the initial history is often incomplete. Witnesses may describe pallor, jerking, incontinence or confusion, while the patient remembers only waking on the floor. Medication lists can also be unreliable, particularly when an older person arrives without family or an accurate medicines record.

The inpatient assessment should establish what happened before, during and after the episode. Questions about posture, exertion, palpitations, chest pain, breathlessness, severe headache, injury and family history of sudden death are central. The clinician should distinguish syncope from seizure, mechanical falls, intoxication, hypoglycaemia and psychogenic episodes without assuming that one unusual feature settles the diagnosis.

Australian context affects the threshold for admission. A low-risk patient living near a major service in Melbourne may be safely managed through rapid outpatient review, while someone from a remote community who faces a long transfer may need a more complete assessment before discharge. Access to cardiac monitoring, echocardiography and follow-up is part of risk management, not an administrative afterthought.

What Changed In Risk Stratification

By May 2017, risk tools were useful prompts rather than replacements for clinical reasoning. The San Francisco Syncope Rule, OESIL score, EGSYS score and ROSE rule had each attracted interest, yet their performance varied across populations and settings. Differences in outcome definitions, ECG interpretation and the proportion of patients admitted made direct comparison difficult.

The emerging Canadian Syncope Risk Score was especially relevant to the period because it combined clinical features, ECG findings, troponin and emergency department diagnosis. Its value lay in estimating short-term serious outcomes across risk bands, not in declaring that a patient was safe regardless of context. A high score should accelerate evaluation; a low score should still be reconsidered if the history is unreliable or the patient has significant comorbidity.

High-risk features consistently included syncope during exertion or while supine, abnormal ECG, known structural or ischaemic heart disease, unexplained hypotension, persistent bradycardia or tachycardia, severe anaemia, major bleeding and a family history of sudden cardiac death. New neurological deficits, ongoing chest pain or suspected pulmonary embolism require assessment for the underlying emergency rather than a generic “syncope work-up”.

History, Examination And ECG

Orthostatic blood pressure and pulse should be measured carefully, with the patient supine and then standing when safe. A meaningful fall in blood pressure, especially with symptoms, supports orthostatic hypotension, although a normal result does not exclude intermittent arrhythmia or reflex syncope. Dehydration, infection, autonomic dysfunction and medicines such as diuretics, vasodilators and antihypertensives deserve specific review.

The cardiovascular examination should assess murmurs suggestive of aortic stenosis, signs of heart failure, irregular rhythm and evidence of poor perfusion. A 12-lead ECG is essential, looking for conduction disease, pre-excitation, prolonged or shortened QT, Brugada-pattern changes, ventricular hypertrophy, ischaemia and atrial fibrillation. A normal ECG lowers concern but does not eliminate a paroxysmal rhythm disorder.

Routine brain imaging and electroencephalography have low yield when the episode is clearly syncopal and the neurological examination is normal. They become appropriate when focal deficits, significant head injury, persistent altered consciousness or a credible seizure history changes the clinical picture. This targeted approach reduces incidental findings and preserves resources for patients with a plausible dangerous cause.

Scores And Their Limits

Risk scores can standardise handover and make uncertainty visible. They are most useful when the clinician records the variables accurately and understands the outcome being predicted, such as a serious event within 30 days. They are less helpful when applied to patients outside the original study population, including those with major trauma, pregnancy, severe renal failure or an already obvious acute diagnosis.

A score should never overrule an unstable patient. It can also understate risk when a patient has multiple modest abnormalities that do not fit neatly into a scoring system. In Australian public hospitals, a clear written rationale is valuable when deciding between admission, observation and discharge, especially during busy overnight periods or when specialist access is limited.

When Admission Is Justified

Admission or monitored observation is generally appropriate when there is a suspected cardiac cause, abnormal ECG, significant injury, persistent abnormal vital signs, severe anaemia, electrolyte disturbance, active bleeding or serious comorbidity. Recurrent unexplained episodes, lack of a prodrome and syncope associated with exertion also deserve a cautious pathway. Patients with suspected pulmonary embolism, acute coronary syndrome or aortic stenosis need disease-specific management.

Telemetry is most valuable when an arrhythmia is plausible and the result could change treatment. It should have a defined purpose and duration rather than becoming passive observation. If the inpatient ECG and monitoring are unrevealing but suspicion remains high, outpatient ambulatory monitoring, an event recorder or an implantable loop recorder may offer more diagnostic value than extending a low-yield admission.

Admission decisions should account for falls risk, frailty, cognitive impairment and medication safety. A patient who lives alone in regional New South Wales may require allied health assessment even when the likely mechanism is orthostatic hypotension. At the same time, syncope alone is not a reason for indiscriminate thromboprophylaxis; the indication should reflect mobility, bleeding risk and the broader medical diagnosis, as discussed in these VTE prophylaxis takeaways.

Testing During The Hospital Stay

Laboratory testing should answer a clinical question. A full blood count is useful when bleeding or anaemia is possible, glucose testing addresses hypoglycaemia, and electrolytes and renal function can reveal medication or volume-related problems. Troponin is appropriate when symptoms, ECG or risk profile suggest myocardial injury, but indiscriminate serial testing can create false positives and unnecessary admissions.

Echocardiography is indicated when structural heart disease is suspected, the examination suggests a murmur or heart failure, or the ECG is abnormal. Carotid imaging is not a routine syncope test, because syncope is rarely caused by isolated carotid disease. Similarly, broad panels of endocrine, infectious or neurological tests should be guided by findings rather than ordered automatically.

Digital systems were beginning to influence hospital medicine in 2017. Predictive analytics could support recognition of deterioration, though they could not replace bedside assessment. The conference discussion of big data and delirium is relevant because a patient admitted after a faint may later develop delirium, medication effects or deconditioning. Monitoring the whole inpatient trajectory is safer than focusing exclusively on the initial collapse.

Translating 2017 Lessons To Australian Wards

Australian services need a tiered pathway that works in both tertiary hospitals and smaller facilities. In Sydney, Brisbane or Perth, rapid access to cardiology and ambulatory monitoring may support early discharge for carefully selected patients. In rural Queensland, the Northern Territory or Western Australia, retrieval logistics and limited overnight diagnostics may justify consultation with a regional centre before transfer or discharge.

Medication reconciliation should include antihypertensives, diuretics, nitrates, sedatives, glucose-lowering drugs and agents that prolong the QT interval. Orthostatic symptoms may improve after adjusting treatment and correcting dehydration, but changes should be individualised in people with heart failure, kidney disease or autonomic dysfunction. Communication with the general practitioner and community pharmacist is particularly important when follow-up occurs across different health services.

Cultural safety and communication matter in every risk assessment. Aboriginal and Torres Strait Islander patients may face transport barriers, fragmented follow-up or previous experiences that affect trust in hospital care; the assessment should involve the patient, family and appropriate liaison support where desired. Private and public hospitals may also use different observation pathways, so the clinical record should state the suspected mechanism, serious causes considered, tests completed and precise return precautions.

The enduring message from the May 2017 update is that syncope risk is a clinical probability, not a label produced by a calculator. Start with the event history, confirm the examination and ECG, search actively for cardiac and systemic danger, then match monitoring and disposition to both medical risk and the patient’s real access to care. The reader should remember that a safe decision is one that explains why serious causes are unlikely, identifies what still needs follow-up and recognises when the hospital environment is necessary.